Cargando…
Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay
BACKGROUND: More than half of the colorectal cancer (CRC) patients will develop liver metastasis that underlies the cancer mortality. In the hepatic tumor microenvironment, the interplay between CRC cells and hepatic stellate cells (HSCs), and the activation of HSCs to become carcinoma-associated fi...
Autores principales: | Fan, Xueying, Meng, Mingjing, Li, Baoting, Chen, Hui, Tan, Jincheng, Xu, Keyang, Xiao, Shilin, Kwan, Hiu-Yee, Liu, Zhongqiu, Su, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105967/ https://www.ncbi.nlm.nih.gov/pubmed/37062842 http://dx.doi.org/10.1186/s12967-023-04087-6 |
Ejemplares similares
-
Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro
por: Meng, Mingjing, et al.
Publicado: (2023) -
Lipid Metabolism Interplay in CRC—An Update
por: Krauß, Dana, et al.
Publicado: (2022) -
CRC handbook of microbiology
Publicado: (1988) -
Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?
por: Saif, Muhammad Wasif
Publicado: (2013) -
CRC concise encyclopedia of mathematics
por: Weisstein, Eric W
Publicado: (2003)